Fujian Medical University Union Hospital

This study tests a new approach for people with a type of esophageal cancer that can be surgically removed. Before surgery, patients receive a treatment plan tailored to their tumor's CPS score, a measure of a protein called PD-L1. The goal is to see if this personalized pre-surg…

This study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after initial chemotherapy. The vaccine is designed to train the immune system to recogn…

This study tests a new way to do stem cell transplants for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). It uses stem cells from a half-matched family donor plus umbilical cord blood, given a few days apart, to help the body accept the new…

This study tests whether a combination of two drugs (zanidatamab and tislelizumab) plus chemotherapy can shrink HER2-positive muscle-invasive bladder cancer enough to allow patients to keep their bladder instead of having it surgically removed. About 25 adults aged 18 to 85 with …

This study tests whether adding silibinin (a liver-protecting supplement from milk thistle) to standard chemotherapy can improve outcomes for adults newly diagnosed with a common type of acute myeloid leukemia (non-M3). About 100 participants will receive either standard chemo al…

This study tests whether tiny particles from umbilical cord stem cells, delivered through microneedles, can safely help regrow hair in men with male pattern baldness. 18 men aged 18-60 with mild to moderate hair loss will receive the treatment. The goal is to see if this cell-fre…

This study looks at whether a protein called leptin, found in bone marrow fluid, can help predict how well chemotherapy will work in adults with acute myeloid leukemia (AML). Researchers will measure leptin levels in 86 newly diagnosed patients before treatment and compare them t…